Pharmaceutical Technology Editors

Gallus Biopharmaceuticals has signed a development and manufacturing supply agreement with Genzyme.

Sanofi Chimie will supply the API avanafil for VIVUS.

Lyophilization Services of New England (LSNE) received a Certificate of GMP Compliance for its New Hampshire facility.

Adamis Pharmaceuticals agrees to license and potentially acquire 3M's Taper Dry Powder Inhaler technology.

The guidance describes a risk-based approach to monitoring of clinical trials.

Donaldson Company, Inc. announced a $10 million expansion of its testing laboratories at its Bloomington, Minn., corporate headquarters.

Advanced Clinical announced the appointment of Cheryle Evans as vice president, Clinical Operations.

America's biopharmaceutical research companies are developing 444 new medicines to prevent and treat neurological disorders, according to a new report released by PhRMA.

Singapore facility delivers manufacturing redundancy and increases supply assurance for global biologic drug discovery and production.

Edwards will oversee company's financial, logistical and human-resources operations.

Selected trendsetters reflect changes in the pharmaceutical industry.

Survey confirms strong link between choice of preferred central laboratory and investigator satisfaction with study sponsors.

A proposed new guideline provides a global policy for limiting metal impurities qualitatively and quantitatively in drug products and ingredients.

A new method of vaccine design, called the Multiple Antigen Presentation System (MAPS), may result in vaccines that bring together the benefits of whole-cell and acellular or defined subunit vaccination.

Wyeth Pharmaceuticals has agreed to pay $490.9 million to resolve its criminal and civil liability arising from the unlawful marketing of the prescription drug Rapamune for uses not approved as safe and effective by FDA.

Perfecseal's high-barrier PVC-free blister-forming web, PerfecForm SkyBlue, is based on polyolefin chemistry, and its new high-barrier flow-wrap specification, PerfecPharm P232, is capable of achieving hermetic seals at the maximum speed capabilities of the top flow-wrap equipment.

Depomed, Inc. announced that FDA has accepted for filing a new drug application (NDA) from Mallinckrodt for MNK-795.

Aesica has appointed Chris Gowland as Chief Operating Officer, a new position created to further enhance the company's operational performance in APIs and formulated product manufacturing services.

Australian team develops method for making ultrafine particles for more efficient drug delivery.

The Muller Group has appointed Dr Christian Heuer as new chief operating officer of Müller AG Cleaning Solutions.

Aptuit has announced that Maurizio Denaro has assumed responsibilities as general manager of The Aptuit Center for Discovery & Development in Verona, Italy.

Charles River has established partnerships with Target Health Inc. and Theorem Clinical Research Inc.

Zeiss announced the acquisition of U.S.-based Xradia, Inc.

FDA conducted a general inspection of operations and quality systems of Albany Molecular Research Inc (AMRI) in Burlington, Mass.

Abbott announces earnings per share above previous guidance range and notes increased sales in emerging markets.

Acquisition database helps extend product lifecycle by seeking new applications for drugs.

Life Technologies Corporation has filed a definitive proxy statement with the US Securities and Exchange Commission regarding Thermo Fisher Scientific Inc.

UK government review will look for unnecessary regulatory burdens and inconsistencies and at guidance clarity.

Bashir Hansraj appointed as Global Technical Director, and David Ross and Sven Thomas appointed as business development managers

Molecular Profiles has opened a new clinical manufacturing facility following a successful inspection from the Medicines and Healthcare products Regulatory Agency.